Abstract:Objective To study the pharmacokinetics and pharmacodynamics of recombinant human insulin preparations SciLin TM R and Humulin (R) R,and to evaluate their bioequivalence in Chinese healthy volunteers.Methods In this positive control,single dose,open label,randomized cross-over study,20 male healthy volunteers were recruited from March to October 2007,and tested on two experimental days with an interval of 7-14 days.The volunteers were divided into two groups with a random number table,one group was injected with SciLin TMR for the first time and Humulin (R) R for the second time,the other group was injected with the opposite.The pharmacokinetics and pharmacodynamic properties were evaluated by euglycemic glucose clamp study.Results Time to peak concentration [Tmax,(105.8 ± 19.1) minutes vs.(103.5 ± 18.1) minutes,P =0.389) and time to maximum glucose infusion rate [TGIRmax,(132.8 ± 16.8) minutes vs.(132.8 ± 18.6) minutes,P =0.697] for SciLin TMR and Humulin(R) R were similar.The relative bioavailability of SciLin TMR was (102.2 ± 7.6) ％,and the relative biological effectiveness was (107.4 ± 18.8) ％.The 90％ confidence interval(CI) of peak concentration(Cmax) and area under the curve of blood glucose concentration at 0-10 hours (AUCIns 0-10) of SciLin TM R were 99.32 ％-102.62 ％ (equivalent range 70％-143 ％) and 98.98 ％-104.99 ％ (equivalent range 80％-125％),respectively;90％ CI of the maximum glucose infusion rate (GIRmax) and AUCGIR0-10 were 97.36％～ 103.49％ (equivalent range 70％-143％) and 98.72％-113.54％ (equivalent range 80％-125％),respectively,indicating that SciLin TMR and Humulin (R) R was bioequivalent.There was no clinically significant abnormalities in the safety indexes before and after the tests.During the trial,no hypoglycemic events,allergic reactions,or local injection adverse reaction occurred.Conclusion The studied recombinant human insulin preparation SciLin TMR may be bioequivalent as Humulin (R) R.

Pharmacodynamic and pharmacokinetic studies of an insulin buccal spray formulation in rats and rabbits

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Comparison of the effects of various absorption enhancers and enzyme inhibitors on buccal insulin delivery in vitro and in vivo

STUDIES ON BUCCAL DELIVERY OF INSULIN FLEXIBLE NANOLIPOSOMES

Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies

Hypoglycaemic effect of insulin by buccal delivery in normal rats

BIOAVAILABILITIES OF INSULIN AEROSOL BY PULMONARY DELIVERY TO RATS

Effects of insulin aerosoll on blood glucose by pulmaonary delivery in normal and diabetic rats

Comparing The Enhancement Efficiency Between Liposomes And Microbubbles For Insulin Pulmonary Absorption

In Vitro and in Vivo Evaluation of a Novel Oral Insulin Formulation

EFFECT OF ENZYMES IN BUCCAL MUCOSA ON INSULIN BUCCAL ABSORPTION

The current situation and prospect of the research on non-injection preparation of insulin

Pharmacokinetics and bioavailability of a new long-acting insulin analog in healthy Chinese volunteers: an open, randomized, single-dose, two-period and two-sequence cross-over study

Studies on Administration and Mechanism of Insulin Oily Formulation

Pharmacokinetics, Pharmacodynamics, and Bioequivalence Study of SciLin TMR Recombinant Human Insulin Injection Preparation

Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles

Effect of enzymes in buccal mucosa in insul in buccal absoption

Cell -penetrating peptide enhanced insulin buccal absorption

Multicenter Clinical Study on the Efficacy and Safety of Inhalable Insulin Aerosol in the Treatment of Type 2 Diabetes.

Insulin hollow suppositories:effect of pH and absorpton enhancer on absorption of insulin

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.